Pharmacological management for BP control and seizure prophylaxis differs between tICH and sICH. ICH etiology should be accounted for in determining appropriate BP goals and the necessity of seizure prophylaxis.

Intracerebral hemorrhage (ICH) is broadly categorized into two types, spontaneous (sICH) and traumatic (tICH), which have different causes, outcomes, and management strategies.

Spontaneous ICH (sICH)
Cause: Typically results from chronic vascular injury in deep brain structures, often due to conditions like hypertension, cerebral amyloid angiopathy, or anticoagulation.
Incidence: Approximately 80,000 cases annually in the U.S.
Mortality: Estimated between 30%−40%.

Traumatic ICH (tICH)
Cause: A subset of traumatic brain injury (TBI) resulting from penetrating or non-penetrating trauma (e.g., falls, motor vehicle accidents) that damages blood vessels and tissue.
Impact: TBI leads to over 200,000 hospitalizations and 70,000 deaths annually, with tICH correlating with poorer neurological outcomes and higher mortality.

Treatment Implication
The etiology (cause) of the ICH is critical because the pharmacological management for key interventions, specifically blood pressure (BP) control and seizure prophylaxis, differs between sICH and tICH. Therefore, treatment plans must be tailored to the specific type of hemorrhage.

Read More